GloPID-R

What GloPID-R does

GloPID-R is a non-profit organization founded in 2013 and headquartered in Berlin, Germany. The firm operates with a minimal staff of 7 employees, reflecting a small secretariat-style organizational structure. Its public-facing web property is maintained at https://www.glopid-r.org/.

The available input data does not characterize GloPID-R's mission, programmatic activities, core products, underlying technology, or target constituencies. No products, services, pricing models, revenue mechanics, customer segments, technology stack, partnerships, awards, or certifications were captured in the source material. The attempted retrieval of the organization's website (http://glopid-r.org/) returned only a bot verification / loading page containing no substantive content, and the firm's legal name, founding date, operating status, and ownership structure are similarly undocumented in the input.

Given the data gap, this description is limited to firmographic facts. A meaningful assessment of GloPID-R's functional role, revenue model, and stakeholder base would require additional primary sources beyond what was provided.

Name

GloPID-R

Website

https://glopid-r.org

Company type

Private

Headcount range

1–10 employees

Short description

GloPID-R is a non-profit organization founded in 2013 and headquartered in Berlin, Germany, operating with a small team of 7 employees. Its mission, products, and stakeholder base are not documented in the available input data.

Ownership category

akta.pro rank

GTM type

B2B

Offering type

Services

Core offering

Unable to determine GloPID-R's core offerings from the provided source material. The only accessible content from the website (http://glopid-r.org/) was a bot verification/loader page containing no substantive information about the organization's activities, products, or services.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Broad incumbents

• Wellcome Trust: Wellcome Trust is a major UK-based research charity funding discovery and applied research in infectious diseases. It is a comparable funder peer whose research-coordination role and global scope overlap with GloPID-R's.
• European Health Emergency Preparedness and Response Authority (HERA): HERA is an EU body established post-COVID to strengthen preparedness and response to health emergencies, including coordinating research and development of medical countermeasures. It is a broader institutional incumbent whose coordination role overlaps GloPID-R's European mandate.
• World Health Organization R&D Blueprint: The WHO R&D Blueprint is a global R&D coordination framework that identifies pathogens of pandemic potential and accelerates research response. It is a broader incumbent that overlaps GloPID-R's mandate on priority-setting and coordinating research preparedness across epidemics.
• Bill & Melinda Gates Foundation: The Gates Foundation is one of the world's largest private funders of global health research, including infectious disease R&D. It is a member-funder peer in GloPID-R's alliance and a benchmark for capital scale in the preparedness-funding ecosystem.
• Chan Zuckerberg Initiative (Biohub Network): CZI funds biomedical research infrastructure and pandemic preparedness through its Biohub Network. It is a peer as a large, mission-driven private funder active in the same infectious-disease preparedness space.

Direct peers

• European & Developing Countries Clinical Trials Partnership (EDCTP): EDCTP is a European-funded partnership that coordinates and funds clinical trial research on infectious diseases in sub-Saharan Africa. It mirrors GloPID-R's role as a multi-funder research coordination entity focused on infectious disease preparedness in low-resource settings.
• Coalition for Epidemic Preparedness Innovations (CEPI): CEPI is a global partnership that coordinates and funds accelerated vaccine development against emerging infectious disease threats. It is the closest direct peer to GloPID-R — both organizations focus on coordinating international research responses to epidemics, with GloPID-R emphasizing funder alignment and CEPI emphasizing vaccine R&D financing.
• Global Antibiotic Research & Development Partnership (GARDP): GARDP is a not-for-profit R&D partnership focused on developing new antibiotic treatments for drug-resistant infections. It shares GloPID-R's public-interest, multi-funder coordination model and global health scope, though concentrated on AMR rather than outbreak preparedness.
• The Pandemic Fund: The Pandemic Fund is a World Bank-hosted financing vehicle that channels grants to low- and middle-income countries for pandemic preparedness. It is a peer in the same funding-and-coordination ecosystem GloPID-R operates in, though with substantially larger capital pools.

Emerging players

• Foundation for Innovative New Diagnostics (FIND): FIND is a non-profit that accelerates development and equitable access to diagnostic tests for infectious diseases. It is a peer in the global health R&D coordination ecosystem with a narrower scope (diagnostics) but comparable multi-funder partnership model.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat1 record

Key risks4 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/glopid-r

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GloPID-R